Matches in SemOpenAlex for { <https://semopenalex.org/work/W2998012193> ?p ?o ?g. }
- W2998012193 endingPage "19" @default.
- W2998012193 startingPage "10" @default.
- W2998012193 abstract "Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) is a debilitating condition that affects 0.2–0.4% of the population. Health focussed anxiety is common across medical conditions, and may be relevant in CFS/ME. This study sought to identify the prevalence and impact of health anxiety (HA) in CFS/ME and evaluate the effectiveness of Cognitive Behavioural Therapy for HA in CFS/ME. Cross-sectional questionnaire methods and case-series design were used to achieve study aims. Analysis indicated that 41.9% of the CFS/ME clinic sample experienced threshold levels of health anxiety, which was associated with elevated symptom severity across several dimensions. Stepwise multiple regression indicated physical functioning and depression accounted for 23.8% of variance in fatigue; depression, fatigue and HA, accounted for 32.9% of variance in physical functioning. Large effect sizes and clinically significant changes were generated in the treatment study. HA is common in CFS/ME and likely to exacerbate fatigue and physical functioning. This study identifies HA as an important target for treatment, trial findings should be further replicated on a larger scale. El Síndrome de Fatiga Crónica/Encefalomielitis Miálgica (SFC/EM) es una enfermedad que afecta al 0,2-0.4% de la población. La ansiedad por la salud (AS) es común en condiciones médicas y puede ser relevante en el SFC/EM. El objetivo de este estudio fue identificar la prevalencia e impacto de la AS en el SFC/EM y evaluar la efectividad de la terapia cognitivo conductual para tratar la AS en el SFC/EM. Se utilizaron cuestionarios en base a un diseño transversal y de estudio de casos. El 41.9% de la muestra clínica de SFC/EM experimentó niveles umbrales de HA, lo que se asoció a una mayor gravedad de algunos síntomas. Modelos de regresión lineal múltiple indicaron que el funcionamiento físico y la depresión representaron el 23.8% de la varianza en la fatiga; la depresión, la fatiga y la AS representaron el 32.9% de la varianza en el funcionamiento físico. Se identificaron grandes tamaños de efecto y cambios clínicamente significativos por el tratamiento. Lla AS es común en el SFC/EM y podría empeorar la fatiga y el funcionamiento físico. Este estudio identifica la HA como factor importante para el tratamiento del SFC/ME. Los resultados deberían replicarse a mayor escala." @default.
- W2998012193 created "2020-01-10" @default.
- W2998012193 creator A5025253816 @default.
- W2998012193 creator A5052867741 @default.
- W2998012193 creator A5077405105 @default.
- W2998012193 date "2020-01-01" @default.
- W2998012193 modified "2023-10-13" @default.
- W2998012193 title "Prevalence and treatment of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and co-morbid severe health anxiety" @default.
- W2998012193 cites W1845447069 @default.
- W2998012193 cites W197066864 @default.
- W2998012193 cites W1975227812 @default.
- W2998012193 cites W1988123433 @default.
- W2998012193 cites W1989869867 @default.
- W2998012193 cites W1995633792 @default.
- W2998012193 cites W2008957823 @default.
- W2998012193 cites W2012565487 @default.
- W2998012193 cites W2017953368 @default.
- W2998012193 cites W2053301520 @default.
- W2998012193 cites W2092312849 @default.
- W2998012193 cites W2098287790 @default.
- W2998012193 cites W2112336497 @default.
- W2998012193 cites W2112370556 @default.
- W2998012193 cites W2112802342 @default.
- W2998012193 cites W2113750014 @default.
- W2998012193 cites W2122883493 @default.
- W2998012193 cites W2134377666 @default.
- W2998012193 cites W2149025988 @default.
- W2998012193 cites W2150393501 @default.
- W2998012193 cites W2166281097 @default.
- W2998012193 cites W2255531323 @default.
- W2998012193 cites W2303635956 @default.
- W2998012193 cites W2314278326 @default.
- W2998012193 cites W2469141562 @default.
- W2998012193 cites W2473786944 @default.
- W2998012193 cites W2525115488 @default.
- W2998012193 cites W2541165905 @default.
- W2998012193 cites W2588727533 @default.
- W2998012193 cites W2594404822 @default.
- W2998012193 cites W2750649941 @default.
- W2998012193 cites W2763823712 @default.
- W2998012193 cites W2767705150 @default.
- W2998012193 cites W4230109046 @default.
- W2998012193 cites W4235813114 @default.
- W2998012193 doi "https://doi.org/10.1016/j.ijchp.2019.11.003" @default.
- W2998012193 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6994737" @default.
- W2998012193 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32021614" @default.
- W2998012193 hasPublicationYear "2020" @default.
- W2998012193 type Work @default.
- W2998012193 sameAs 2998012193 @default.
- W2998012193 citedByCount "12" @default.
- W2998012193 countsByYear W29980121932020 @default.
- W2998012193 countsByYear W29980121932021 @default.
- W2998012193 countsByYear W29980121932022 @default.
- W2998012193 crossrefType "journal-article" @default.
- W2998012193 hasAuthorship W2998012193A5025253816 @default.
- W2998012193 hasAuthorship W2998012193A5052867741 @default.
- W2998012193 hasAuthorship W2998012193A5077405105 @default.
- W2998012193 hasBestOaLocation W29980121931 @default.
- W2998012193 hasConcept C118552586 @default.
- W2998012193 hasConcept C139719470 @default.
- W2998012193 hasConcept C15744967 @default.
- W2998012193 hasConcept C162324750 @default.
- W2998012193 hasConcept C1862650 @default.
- W2998012193 hasConcept C2776867660 @default.
- W2998012193 hasConcept C2779566273 @default.
- W2998012193 hasConcept C2908647359 @default.
- W2998012193 hasConcept C558461103 @default.
- W2998012193 hasConcept C70410870 @default.
- W2998012193 hasConcept C71924100 @default.
- W2998012193 hasConcept C99454951 @default.
- W2998012193 hasConceptScore W2998012193C118552586 @default.
- W2998012193 hasConceptScore W2998012193C139719470 @default.
- W2998012193 hasConceptScore W2998012193C15744967 @default.
- W2998012193 hasConceptScore W2998012193C162324750 @default.
- W2998012193 hasConceptScore W2998012193C1862650 @default.
- W2998012193 hasConceptScore W2998012193C2776867660 @default.
- W2998012193 hasConceptScore W2998012193C2779566273 @default.
- W2998012193 hasConceptScore W2998012193C2908647359 @default.
- W2998012193 hasConceptScore W2998012193C558461103 @default.
- W2998012193 hasConceptScore W2998012193C70410870 @default.
- W2998012193 hasConceptScore W2998012193C71924100 @default.
- W2998012193 hasConceptScore W2998012193C99454951 @default.
- W2998012193 hasFunder F4320323000 @default.
- W2998012193 hasIssue "1" @default.
- W2998012193 hasLocation W29980121931 @default.
- W2998012193 hasLocation W29980121932 @default.
- W2998012193 hasLocation W29980121933 @default.
- W2998012193 hasLocation W29980121934 @default.
- W2998012193 hasLocation W29980121935 @default.
- W2998012193 hasLocation W29980121936 @default.
- W2998012193 hasOpenAccess W2998012193 @default.
- W2998012193 hasPrimaryLocation W29980121931 @default.
- W2998012193 hasRelatedWork W1882736447 @default.
- W2998012193 hasRelatedWork W1976433721 @default.
- W2998012193 hasRelatedWork W1984450594 @default.
- W2998012193 hasRelatedWork W2090007074 @default.
- W2998012193 hasRelatedWork W2378173657 @default.
- W2998012193 hasRelatedWork W2414935542 @default.